Intravenous (IV) Therapy Complications

Clinical Pharmacist Overview

Intravenous (IV) therapy is widely used for the administration of fluids, medications, blood products, and nutrition. Despite its effectiveness, IV therapy is associated with local, systemic, mechanical, and infectious complications. Early recognition and prevention are essential to minimize patient harm and optimize pharmacotherapy outcomes.

1. Local Complications

Infiltration

Definition: Leakage of non-vesicant solution into surrounding tissue due to catheter displacement.

Clinical Signs

  • Swelling, cool skin
  • Pallor, discomfort
  • Slowed or stopped infusion

Pharmacist Role

  • Assess vesicant vs non-vesicant drugs
  • Recommend dilution, slower infusion rates
  • Ensure appropriate catheter size and site selection

Extravasation

Definition: Leakage of vesicant or irritant drugs into surrounding tissue, potentially causing tissue necrosis.

Common Drugs

Clinical Signs

  • Pain, burning, blistering
  • Tissue necrosis (severe cases)

Pharmacist Role

Phlebitis

Definition: Inflammation of the vein.

Causes

  • Mechanical (large catheter, poor stabilization)
  • Chemical (hyperosmolar or acidic solutions)
  • Infectious

Clinical Signs

  • Redness, warmth
  • Pain along vein
  • Palpable cord

Pharmacist Role

  • Review solution pH and osmolarity
  • Recommend central access for irritant medications
  • Ensure appropriate dilution and infusion rates

Hematoma

Definition: Blood leakage into surrounding tissue during or after catheter insertion.

Clinical Signs

  • Bruising, swelling
  • Local pain

Pharmacist Role

  • Minimal direct role; ensure anticoagulation risk is considered

2. Infectious Complications

Local Site Infection

Definition: Infection limited to the IV insertion site.

Clinical Signs

  • Erythema, warmth
  • Purulent drainage

Pharmacist Role

  • Evaluate need for empiric antimicrobial therapy
  • Reinforce aseptic technique and catheter care

Definition: Systemic infection caused by microorganisms entering via an IV catheter.

Risk Factors

  • Central venous catheters
  • Prolonged catheter dwell time
  • Poor aseptic technique

Clinical Signs

  • Fever, chills
  • Positive blood cultures

Pharmacist Role

  • Optimize antimicrobial selection and duration
  • Adjust dosing based on renal function
  • Monitor for antimicrobial resistance

3. Mechanical Complications

Catheter Occlusion

Definition: Blockage due to thrombus, precipitate, or kinking.

Causes

  • Drug incompatibility
  • Inadequate flushing
  • Fibrin sheath formation

Pharmacist Role

  • Check IV compatibility
  • Recommend proper flushing protocols
  • Identify precipitation risks (e.g., calcium + phosphate)

Air Embolism

Definition: Entry of air into the venous system.

Clinical Signs

  • Sudden dyspnea
  • Chest pain
  • Hypotension

Pharmacist Role

  • Rare; reinforce proper line priming and pump use

4. Systemic Complications

Fluid Overload

Definition: Excessive IV fluid administration leading to volume expansion.

High-Risk Patients

Clinical Signs

  • Edema
  • Pulmonary congestion
  • Hypertension

Pharmacist Role

  • Review IV fluid type and rate
  • Recommend fluid restriction or diuretics when appropriate

Electrolyte Imbalances

Examples

  • Hyperkalemia (potassium-containing fluids)
  • Hypernatremia or hyponatremia
  • Hyperchloremic metabolic acidosis (normal saline)

Pharmacist Role

  • Monitor labs
  • Adjust IV fluid composition
  • Recommend alternative solutions (e.g., balanced crystalloids)

Speed Shock

Definition: Adverse reaction due to rapid IV administration of certain drugs.

Common Drugs

  • Vancomycin
  • Amphotericin B
  • Phenytoin

Clinical Signs

  • Hypotension
  • Flushing
  • Dyspnea

Pharmacist Role

  • Enforce correct infusion rates
  • Educate nursing staff
  • Recommend premedication when indicated

5. Thrombotic Complications

Definition: Formation of a thrombus at or near the catheter site.

Clinical Signs

  • Swelling of limb
  • Pain
  • Catheter dysfunction

Pharmacist Role

  • Assess anticoagulation therapy
  • Monitor for drug interactions and bleeding risk

Summary Table (Quick Reference)

 

Category Complication Key Risk
Local Infiltration Poor catheter placement
Local Extravasation Vesicant drugs
Infectious CRBSI Prolonged catheter use
Mechanical Occlusion Drug incompatibility
Systemic Fluid overload Renal/cardiac disease
Thrombotic Catheter thrombosis Central lines